Skip to main content
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Features
Assistant
AI grounded in research
Search
Full-text citation search
Collections
Organize and monitor papers
All Features →
Integrations
MCP
Connect AI agents to Scite
API
Programmatic data access
Holdings
Full-text via your library
Zotero Plugin
Citation data in Zotero
Browser Extension
Citation badges anywhere
All Integrations →
Data
Rankings
Pricing
Log In
Start Free Trial
Karl Herholz
Sign up to set email alerts
616
Publications
17,197
Citation Statements Received
12,870
Citation Statements Given
How they've been cited
26,330
894
16,226
77
How they cite others
22,336
841
11,936
93
Affiliations
University of Manchester
,
Max Planck Society
Publications
Order By: Most citations
Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations
Young
1
,
Baum
2
,
Cremerius
3
et al.
1999
European Journal of Cancer
1,706
14
1,155
2
Get access via publisher
Add to collection
Cite
Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET
Herholz
1
,
Salmon
2
,
Perani
3
et al.
2002
NeuroImage
844
53
613
0
Get access via publisher
Add to collection
Cite
Multicenter Standardized
18
F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias
Mosconi
1
,
Tsui
2
,
Herholz
3
et al.
2008
J Nucl Med
Abstract
Show
758
35
570
1
Get access via publisher
Add to collection
Cite
Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers
Frisoni
1
,
Boccardi
2
,
Barkhof
3
et al.
2017
The Lancet Neurology
Abstract
Show
662
3
601
0
Get access via publisher
Add to collection
Cite
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
Chételat
1
,
Arbizu
2
,
Barthel
3
et al.
2020
The Lancet Neurology
568
15
465
0
Get access via publisher
Add to collection
Cite
Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives
Hampel
1
,
Frank
2
,
Broich
3
et al.
2010
Nat Rev Drug Discov
Abstract
Show
632
7
459
0
Get access via publisher
Add to collection
Cite
Astrocyte Biomarkers in Alzheimer’s Disease
Carter
1
,
Herholz
2
,
Rosa‐Neto
3
et al.
2019
Trends in Molecular Medicine
388
13
300
0
Get access via publisher
Add to collection
Cite
MCI conversion to dementia and the
APOE
genotype
Mosconi
1
,
Perani
2
,
Sorbi
3
et al.
2004
Neurology
Abstract
Show
351
31
252
5
Get access via publisher
Add to collection
Cite
1
2
3
4